MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma
Authors
Keywords
-
Journal
HUMAN MOLECULAR GENETICS
Volume 22, Issue 5, Pages 904-918
Publisher
Oxford University Press (OUP)
Online
2012-12-01
DOI
10.1093/hmg/dds496
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK
- (2012) Simiao Fan et al. FREE RADICAL RESEARCH
- Expression of miRNAs and PTEN in endometrial specimens ranging from histologically normal to hyperplasia and endometrial adenocarcinoma
- (2012) Heejeong Lee et al. MODERN PATHOLOGY
- miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production
- (2011) Ana L. Cardoso et al. IMMUNOLOGY
- Inflammation meets cancer, with NF-κB as the matchmaker
- (2011) Yinon Ben-Neriah et al. NATURE IMMUNOLOGY
- Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo
- (2011) A. B. Gaur et al. NEURO-ONCOLOGY
- Glioblastoma Models Reveal the Connection between Adult Glial Progenitors and the Proneural Phenotype
- (2011) Liang Lei et al. PLoS One
- Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma
- (2011) Joana Heinzelmann et al. WORLD JOURNAL OF UROLOGY
- MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol
- (2010) Yu Ren et al. BMC CANCER
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- p53 and NF-κB: different strategies for responding to stress lead to a functional antagonism
- (2010) Prashanth Ak et al. FASEB JOURNAL
- Silencing ataxin-3 mitigates degeneration in a rat model of Machado–Joseph disease: no role for wild-type ataxin-3?
- (2010) Sandro Alves et al. HUMAN MOLECULAR GENETICS
- Neuropeptide Y Modulation of Interleukin-1β (IL-1β)-induced Nitric Oxide Production in Microglia
- (2010) Raquel Ferreira et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Co-delivery of as-miR-21 and 5-FU by Poly(amidoamine) Dendrimer Attenuates Human Glioma Cell Growth in Vitro
- (2010) Yu Ren et al. JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
- A non-covalent strategy combining cationic lipids and CPPs to enhance the delivery of splice correcting oligonucleotides
- (2010) Sara Trabulo et al. JOURNAL OF CONTROLLED RELEASE
- PI3Kinase signaling in glioblastoma
- (2010) M. M. Lino et al. JOURNAL OF NEURO-ONCOLOGY
- Phase II study of sunitinib malate in patients with recurrent high-grade glioma
- (2010) B. Neyns et al. JOURNAL OF NEURO-ONCOLOGY
- Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status
- (2010) Xuan Zhou et al. LABORATORY INVESTIGATION
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Pifithrin-α, an Inhibitor of p53 Transactivation, Up-Regulates COX-2 Expression through an MAPK-Dependent Pathway
- (2010) Sangmin Kim et al. PHARMACOLOGY
- Novel targeted agents for platelet-derived growth factor receptor and c-KIT in malignant gliomas
- (2010) Patrick G. Morris et al. Targeted Oncology
- Advances in the Treatment of Malignant Gliomas
- (2010) Mustafa Khasraw et al. Current Oncology Reports
- miR-21as a key regulator of oncogenic processes
- (2009) S. Duygu Selcuklu et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Emerging functions of microRNAs in glioblastoma
- (2009) Sean Lawler et al. JOURNAL OF NEURO-ONCOLOGY
- miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors
- (2009) Alfredo Conti et al. JOURNAL OF NEURO-ONCOLOGY
- Drugs targeting the mitochondrial pore act as citotoxic and cytostatic agents in temozolomide-resistant glioma cells
- (2009) Annalisa Lena et al. Journal of Translational Medicine
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- miRNA in situ hybridization in formaldehyde and EDC–fixed tissues
- (2009) John T G Pena et al. NATURE METHODS
- The microRNA network and tumor metastasis
- (2009) H Zhang et al. ONCOGENE
- miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
- (2008) Joachim Silber et al. BMC Medicine
- MicroRNA-21 down-regulates the expression of tumor suppressor PDCD4 in human glioblastoma cell T98G
- (2008) Yang Chen et al. CANCER LETTERS
- Targeting of the Bmi-1 Oncogene/Stem Cell Renewal Factor by MicroRNA-128 Inhibits Glioma Proliferation and Self-Renewal
- (2008) J. Godlewski et al. CANCER RESEARCH
- MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
- (2008) T. Papagiannakopoulos et al. CANCER RESEARCH
- MicroRNA-21 targets tumor suppressor genes in invasion and metastasis
- (2008) Shuomin Zhu et al. CELL RESEARCH
- MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
- (2008) G. Gabriely et al. MOLECULAR AND CELLULAR BIOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
- (2008) Z Lu et al. ONCOGENE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started